|
Volumn 65, Issue 2, 1998, Pages 235-241
|
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection
a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
GRAFT REJECTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY ALLOGRAFT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
TREATMENT INDICATION;
TREATMENT PLANNING;
ADULT;
ANALYSIS OF VARIANCE;
AZATHIOPRINE;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
SURVIVAL ANALYSIS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0032570310
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (65)
|
References (21)
|